Company · CIK 1683553
SPRUCE BIOSCIENCES, INC.
| CIK | 1683553 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | SPRB (Nasdaq) |
| First annual or quarterly report | 2020-11-18 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-291152 | 2025-10-29 | 2026-04-21 | 5 | |
| 333-291153 | 2025-10-29 | 2025-11-26 | 2 | |
| 333-270612 | 2023-03-16 | 2023-04-07 | 2 | |
| 333-261960 | 2021-12-30 | 2022-02-28 | 3 | |
| 333-248924 | 2020-09-18 | 2020-10-09 | 4 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-21 | 424B5Shelf takedown | 333-291152 | 0001193125-26-167256 |
| 2026-04-20 | 424B5Shelf takedown | 333-291152 | 0001193125-26-163919 |
| 2026-03-09 | 424B5Shelf takedown | 333-291152 | 0001193125-26-097569 |
| 2025-11-26 | EFFECTDeclared effective | 333-291153 | 9999999995-25-003404 |
| 2025-11-26 | EFFECTDeclared effective | 333-291152 | 9999999995-25-003403 |
| 2025-10-29 | S-3Shelf registered | 333-291153 | 0001193125-25-256668 |
| 2025-10-29 | S-3Shelf registered | 333-291152 | 0001193125-25-256662 |
| 2023-04-07 | EFFECTDeclared effective | 333-270612 | 9999999995-23-000869 |
| 2023-03-16 | S-3Shelf registered | 333-270612 | 0001564590-23-003806 |
| 2022-02-28 | 424B5Shelf takedown | 333-261960 | 0001564590-22-007241 |
| 2022-02-11 | EFFECTDeclared effective | 333-261960 | 9999999995-22-000422 |
| 2021-12-30 | S-3Shelf registered | 333-261960 | 0001564590-21-061772 |
| 2020-10-09 | 424B4Final prospectus | 333-248924 | 0001193125-20-267295 |
| 2020-10-08 | EFFECTDeclared effective | 333-248924 | 9999999995-20-002790 |
| 2020-10-05 | S-1/AAmendment | 333-248924 | 0001193125-20-263195 |
| 2020-09-18 | S-1Registration filed | 333-248924 | 0001193125-20-249221 |
| 2020-08-07 | DRSDraft made public | 377-03390 | 0000950123-20-007952 |